All articles
Zepbound® Side Effects: Causes and How To Manage Them
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
When to Seek Medical Advice For Zepbound® Side Effects
Seek immediate medical attention if you experience severe side effects, including signs of allergic reactions, severe gastrointestinal distress, or symptoms indicating low blood sugar. It's also essential to consult healthcare professionals if you have concerns about the medication's impact on existing health conditions or if you are pregnant.
There may also be alternative medications that are better tolerated in some patients. Your Mochi Health provider can help assess your health history to determine what the right medication and dosage is for you. Explore other medications options here: https://joinmochi.com/medications
Key Takeaways For Managing Zepbound® Side Effects
Zepbound® is a powerful tool for combating obesity and overweight. For those who have struggled with traditional methods of weight loss, Zepbound® provides an alternative path to a healthier you. While it has some side effects, working with your healthcare provider can help you manage them effectively.
Interested in a comprehensive approach to obesity medicine? Mochi Health tailors weight management programs specifically for you, incorporating medications like Zepbound® with support from licensed physicians and nutrition experts. With medications delivered directly to your door and 24/7 customer support, managing your weight has never been more convenient. Discover how Mochi Health can support your weight management goals. Check your eligibility for our program here.
References:
Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N. N., Bunck, M. C., Benabbad, I., Zhang, X. M., Abalos, F. H., Manghi, F. C. P., Zaidman, C. J., Vico, M. L., Aizenberg, D., Costanzo, P. R., Serra, L. P., … Jones, T. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet (British Edition), 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
Rebitch, C. B. (2023). Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus. American Family Physician, 108(1), 93–94.
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. The New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
What is5. Zepbound® | Zepbound® (tirzepatide). (n.d.). https://Zepbound®.lilly.com/what-is-zepbound
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles















